Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Safety, Tolerability, Preliminary Pharmacokinetics and Pharmacodynamics of Single Ascending Oral Doses of MYK-461 in Patient Volunteers With Hypertrophic Cardiomyopathy

NCT02329184 is registered in ClinicalTrials.gov with MyoKardia, Inc. as lead sponsor.

NCT NCT02329184
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT02329184 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Safety, Tolerability, Preliminary Pharmacokinetics and Pharmacodynamics of Single Ascending Oral Doses of MYK-461 in Patient Volunteers With Hypertrophic Cardiomyopathy
Lead sponsor
MyoKardia, Inc.
Phase
Phase 1
Overall status
Completed
Start date
December 31, 2014
Completion date
April 30, 2016
Enrollment
15 (actual)
Sites
7

Conditions

As the registry lists them; a condition with its own page is linked.

hypertrophic cardiomyopathy